Overexpression of protein S100A4 is independently associated with overall survival in stage C colonic cancer but only in cytoplasm at the advancing tumour front

International Journal of Colorectal Disease

Volumn 27, Issue 11, 2012, Pages 1409-1417

  Kho, P S S ^a   Jankova, L ^a   Fung, C L S ^a   Chan, C ^b   Clarke, C ^a   Lin, B P C ^b   Robertson, G ^a   Molloy, M ^c   Chapuis, P H ^b   Bokey, E L ^b   Dent, O F ^b   Clarke, S ^b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

Colonic cancer; Overall survival; Prognosis; S100A4; Stage C

Indexed keywords

ANTINEOPLASTIC AGENT; CALVASCULIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CELL NUCLEUS; COLON CANCER; CYTOPLASM; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; COLONIC NEOPLASMS; CYTOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REGRESSION ANALYSIS; S100 PROTEINS; STAINING AND LABELING; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84867997842     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1469-8     Document Type: Article

References (25)

1. Mazzucchelli L (2002) Protein S100A4: Too long overlooked by pathologists? Am J Pathol 160:7-13
2. Garrett SC, Varney KM, Webber DJ (2006) S100A4, a mediator of metastasis. J Biol Chem 281:677-680
3. Boye K, Mælandsmo M (2010) S100A4 and metastasis: A small actor playing many roles. Am J Pathol 176:528-535
4. Takenaga K, Nakanishi H, Wada K, Suzuki M, Matsuzaki O, Matasuura A, Endo H (1997) Increased expression of S100A4, a metastasis-associated gene in human colorectal adenocarcinomas. Clin Cancer Res 3:2309-2316
5. Bronckart Y, Decaestecker C, Nagy N, Harper L, Schäfer BW, Salmon I, Pochet R, Kiss R, Heizman CW (2001) Development and progression of malignancy in human colon tissues and correlated with expression of specific Ca2+-binding S100 proteins. Histol Histopathol 16:707-712
6. Taylor S, Herrington S, Prime W, Rudland PS, Barraclough R (2002) S100A4 (p9Ka) protein in colon carcinoma and liver metastases: Association with carcinoma cells and T-lymphocytes. Br J Cancer 86:409-416
7. Flatmark K, Pedersen KB, Nesland JM, Rasmussen K, Aamodt G, Mikalsen S-O, Bjørnland K, Fodstad Ø, Mælandsmo GM (2003) Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. J Pathol 200:589-595
8. Kim JH, Kim CN, Kim SY, Lee JS, Cho D, Kim JW, Yoon SY (2009) Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer. Oncol Rep 22:41-47
9. Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H, Von Wasielewski R (2002) Prognostic significance of calciumbinding protein S100A4 in colorectal cancer. Gastroenterology 123:1478-1484
10. Cho YG, Kim CJ, Nam SW, Yoon SH, Lee SH, Yoo NJ, Lee JY, Park WS (2005) Overexpression of S100A4 is closely associated with progression of colorectal cancer.World J Gastroenterol 11:4852-4856
11. Hemandas AK, Salto-Tellez M, Maricar SH, Leong AFPK, Leow CK (2006) Metastasis-associated protein S100A4-a potential prognostic marker for colorectal cancer. J Surg Oncol 93:498-503
12. Wang HY, Zhang JY, Cui JT, Tan XH, Li WM, Gu J, Lu YY (2010) Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep 23:45-52
13. Boye K, Nesland JM, Sandstad B et al (2010) Nuclear S100A4 is a novel prognostic marker in colorectal cancer. Eur J Cancer 46:2919-2925
14. NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450
15. Andre T, Boni C, Navaro M et al (2009) Improved overall survival with oxaliplatin, fluourouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116
16. Twelves C, Wong A, Nowacki MP et al (2005) Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352:2696-2704
17. Andre T, Colin P, Louvet C (2003) Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: Results of a randomized trial. J Clin Oncol 21:2896-2903
18. Newland RC, Chapuis PH, Pheils MT, Macpherson JG (1981) The relationship of survival to staging and grading of colorectal carcinoma. A prospective study of 503 cases. Cancer 47:1424-1429
19. Newland RC, Chapuis PH, Smyth EJ (1987) The prognostic value of substaging in colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer 60:852-857
20. Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC (2003) Surgical technique in patients having a curative resection for colon cancer. Dis Colon Rectum 46:860-866
21. Davis NC, Newland RC (1983) Terminology and classification of colorectal adenocarcinoma: The Australian Clinico-pathological Staging System. Aust NZ J Surg 53:211-221
22. Chan C, Jankova L, FungCL-S, Clarke C, RobertsonG, Chapuis PH, Bokey L, Lin BPC, Dent OF, Clarke S (2010) Fascin expression predicts survival after potentially curative resection of node-positive colon cancer. Am J Surg Pathol 34:656-666
23. Fung CL-S, Chan C, Jankova L, Dent OF, Robertson G, Molloy M, Bokey L, Chapuis PH, Lin BPC, Clarke SJ (2010) Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node-positive colonic cancer. Histopathology 56:319-330
24. Fielding LP, Arsenault PA, Chapuis PH, Gathright B, Hardcastle JD, Hermanek P, Jass JR, Newland RC (1991) Clinicopathological staging for colorectal cancer: An international documentation (IDS) and an international comprehensive anatomical terminology (ICAT). J Gastroenterol Hepatol 6:325-344
25. Zlobec I, Lugli A (2009) Invasive front of colorectal cancer: Dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 15:5895-5906